The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Codant 30 mg Tablets

Mercury Pharmaceuticals (Ireland) LtdPA0073/029/001

Main Information

Trade NameCodant 30 mg Tablets
Active SubstancesCodeine phosphate hemihydrate
Dosage FormTablet
Licence HolderMercury Pharmaceuticals (Ireland) Ltd
Licence NumberPA0073/029/001

Group Information

ATC CodeR05DA Opium alkaloids and derivatives
R05DA04 codeine


License statusAuthorised
Licence Issued01/04/1978
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back